EpiBone

Other Healthcare Technology Systems · New York, NY · Founded 2013 · Privately Held (backing)

Developer of a bone reconstruction technology designed for skeletal reconstruction through three-dimensional design and living cells. EpiBone is based in New York, NY and was founded in 2013. Its last reported valuation was $44.3 million in Jan 2020. It has raised $71.1 million across 4 recorded rounds; the latest was a $4.3 million seed round in Sep 2025.

Last reported valuation
$44.3M
Oct 2026
Priced at
—
Total raised
$71.1M
Last round
Seed Round
Sep 2025
Cap table — not yet on record

EpiBone's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of EpiBone with a free account
  • ·The complete investor list: 50 names
  • ·Watch EpiBone: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about EpiBone

Where does EpiBone's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across EpiBone's 4 recorded funding rounds.